Population monitoring of coronary heart disease in the modern era

尽管在过去30年中，心脏病发作的死亡率大幅下降，但在澳大利亚，冠心病(CHD)仍然是导致死亡和残疾的主要原因。它产生了非常大的卫生成本，是国家疾病预防和控制的五个优先领域之一。冠心病最重要的表现是心脏病发作，需要紧急住院治疗，或猝死，通常在医院外。监测心脏病发作发生率和结果的趋势的准确信息至关重要，这些信息可用于评估公共卫生计划的有效性，建立临床服务要求，提高护理质量，并支持对卫生保健成本的研究。这项研究将利用西澳大利亚州独特的医疗记录关联能力，建立一个全面的系统来监测心脏病发作的发生率、结果和紧急治疗。它将结合来自多个数据来源的信息，包括医院统计系统、急诊科、救护车服务、实验室和心脏病部门。它还将从英联邦卫生和老年保健部获得有关选定药物的处方信息，例如用于预防心脏病的降胆固醇药物。在这一框架内，它将开展若干分研究，以提高医院统计系统中心脏病发作信息的准确性，以确保衡量未来趋势的一致性，向全州临床医生提供关于医院护理结果和采用成熟疗法的信息，为卫生行政人员提供规划服务的信息，并向政策制定者提供预防和控制心脏病的最具成本效益的选择。

Despite major reductions in mortality from heart attack over the past three decades, coronary heart disease (CHD) remains the leading cause of death and disability in Australia. It generates very large health costs and is one of five National priority areas for disease prevention and control. The most important manifestations of CHD are heart attacks, which require urgent hospital treatment, or sudden death, generally outside hospital. Accurate information to monitor trends in the incidence and outcomes of heart attack that can be used to assess the effectiveness for public health programs, establish requirements for clinical services, improve quality of care, and support studies of costs of health care, is essential. This study will use the unique capacity for medical record linkage in Western Australia (WA) to establish a comprehensive system to monitor the incidence, outcomes and emergency treatment of heart attack. It will combine information from a number of data sources including the hospital statistical system, emergency departments, ambulance services, laboratories and departments of cardiology. It will also obtain information from Commonwealth Department of Health and Aged care about the prescribing of selected medications, such as cholesterol lowering drugs, used in for the prevention of heart disease. Within this framework, it will undertake a number of sub-studies to improve the accuracy of information about heart attacks in the hospital statistical system to ensure consistency in measuring future trends, provide clinicians with state-wide information about outcomes of hospital care and the uptake of proven therapies, provide health administrators with information for planning services, and policy makers about the most cost-effective options for the preventions and control of heart disease.